NYAS Conferences
New York Academy of Sciences
left end
Search
divider divider feedback right end
Annals of the New York Academy of Sciences Annals of the New York Academy of Sciences login

Main

Browse Volumes

Forthcoming Volumes

Annals PrePrints

Annals Extra

E-mail Alerts

Subscriptions & Orders

New Proposals

Author Guidelines

About Annals

Help

Get free Annals volume as a NYAS member: http://www.nyas.org/annalsreaderhw
Issue 995 coverTISSUE REMODELING Copyright © 2003 by the New York Academy of Sciences
description

This Volume
Table of Contents
Description
This Article
Full Text
Full Text (PDF)
Services
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Citing Articles
Citing Articles via HighWire
Citing Articles via Google Scholar
Google Scholar
Articles by REITER, J. L.
Articles by MAIHLE, N. J.
Search for Related Content
PubMed
PubMed Citation
Articles by REITER, J. L.
Articles by MAIHLE, N. J.
Annals of the New York Academy of Sciences 995:39-47 (2003)
© 2003 New York Academy of Sciences

Characterization and Expression of Novel 60-kDa and 110-kDa EGFR Isoforms in Human Placenta

JILL L. REITER AND NITA J. MAIHLE

Tumor Biology Program, Mayo Clinic, Rochester, Minnesota 55905, USA

Address for correspondence: Nita J. Maihle, Ph. D., 200 First Street SW, Rochester, MN 55905. Voice: 507-284-0279; fax: 507-284-1767.
maihle{at}mayo.edu
Ann. N.Y. Acad. Sci. 995: 39-47 (2003).

The epidermal growth factor receptor (EGFR) and related family members (ERBB2, ERBB3, and ERBB4) previously have been shown to play pivotal roles in the development of female reproductive tissues, in blastocyst implantation, and in placental differentiation. We have cloned and sequenced several naturally occurring alternative transcripts of the human and mouse EGFR genes, which encode novel receptor isoforms containing varying portions of the extracellular ligand-binding domain, but lacking the transmembrane and cytoplasmic domain sequences. The human 1.8-kb and 3-kb alternative EGFR transcripts encode secreted 60-kDa and cell surface-associated 110-kDa EGFR isoforms, respectively. We have developed quantitative ribonuclease protection assays to study the expression of these alternative transcripts in human tissues. Similar to the full-length EGFR mRNAs, the highest expression level of these alternative transcripts occurs in placenta. We speculate that both of these EGFR isoforms may be important regulators of EGF-mediated cell growth and differentiation in human placenta.

Key Words: alternative splicing • cell fractionation • epidermal growth factor receptor • glycoprotein • isoforms • placenta • posttranslational protein modification • receptor tyrosine kinase




This article has been cited by other articles:


Home page
EndocrinologyHome page
R. G. Humphrey, C. Sonnenberg-Hirche, S. D. Smith, C. Hu, A. Barton, Y. Sadovsky, and D. M. Nelson
Epidermal Growth Factor Abrogates Hypoxia-Induced Apoptosis in Cultured Human Trophoblasts through Phosphorylation of BAD Serine 112
Endocrinology, May 1, 2008; 149(5): 2131 - 2137.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. M. Giltnane, L. Ryden, M. Cregger, P.-O. Bendahl, K. Jirstrom, and D. L. Rimm
Quantitative Measurement of Epidermal Growth Factor Receptor Is a Negative Predictive Factor for Tamoxifen Response in Hormone Receptor Positive Premenopausal Breast Cancer
J. Clin. Oncol., July 20, 2007; 25(21): 3007 - 3014.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
H. Xu, Y. Yu, D. Marciniak, A. K. Rishi, F. H. Sarkar, O. Kucuk, and A. P.N. Majumdar
Epidermal growth factor receptor (EGFR)-related protein inhibits multiple members of the EGFR family in colon and breast cancer cells
Mol. Cancer Ther., March 1, 2005; 4(3): 435 - 442.
[Abstract] [Full Text] [PDF]



footerLeft footerRight